文献速递外周动脉疾病血液透析通路

外周动脉疾病进展预测透析通路术后不良结局

Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery.
PubMed 文献 · J Vasc Surg · 2026-06-10

基于Vascular Quality Initiative数据库2011至2024年78,607例上肢透析通路创建患者,评估PAD严重程度与术后并发症及6个月初级通畅率的关系。结果显示PAD严重程度独立关联30天死亡率、术后出血、窃血综合征及6个月初级通畅丢失,且无症状PAD亦显著增加死亡和通畅丢失风险,提示应将PAD状态纳入术前风险分层和通路规划。

要点

  • PAD严重程度越高,透析通路术后30天死亡风险逐级增加。
  • 即使无症状PAD,6个月初级通畅丢失风险也显著升高。
  • 跛行和CLTI与窃血综合征风险增加相关,PAD严重程度与术后血栓无关。

核心结论

  • PAD严重程度独立关联透析通路术后并发症、30天死亡率和6个月初级通畅丢失。
  • 无症状PAD也显著增加死亡和6个月初级通畅丢失风险。
  • 应将PAD状态纳入术前风险分层和透析通路规划。

研究设计与样本

  • 回顾性队列研究,使用Vascular Quality Initiative数据库2011至2024年数据。
  • 纳入78,607例接受上肢血液透析通路创建的患者。
  • PAD状态分为无PAD、无症状PAD、跛行和慢性肢体威胁性缺血(CLTI)。
  • 采用多因素logistic回归和Cox回归分析,并按AVF和AVG分层。

主要发现

  • 与无PAD相比,无症状PAD(aOR 1.55;95%CI 1.27-1.90;P<.001)、跛行(aOR 2.20;95%CI 1.52-3.18;P<.001)和CLTI(aOR 3.01;95%CI 2.24-4.06;P<.001)与30天死亡风险逐级升高相关。
  • 无症状PAD(aOR 1.41;95%CI 1.16-1.71;P<.001)和CLTI(aOR 2.27;95%CI 1.82-2.83;P<.001)与住院时间延长相关。
  • 无症状PAD与术后出血风险增加相关(aOR 1.30;95%CI 1.01-1.69;P=.043)。
  • 跛行(aOR 3.57;95%CI 1.33-9.59;P=.012)和CLTI(aOR 2.87;95%CI 1.21-6.82;P=.017)与窃血综合征风险增加相关。
  • 6个月时,无症状PAD(aHR 5.09;95%CI 3.15-8.22;P<.001)、跛行(aHR 4.79;95%CI 2.86-8.02;P<.001)和CLTI(aHR 5.05;95%CI 3.14-8.10;P<.001)均与初级通畅丢失强烈相关。

临床怎么用

  • 术前应评估PAD状态,包括无症状PAD,用于风险分层和通路规划。
  • 对合并PAD的透析通路患者,应加强围手术期监测和术后随访。
  • PAD严重程度可用于预判30天死亡、出血、窃血综合征和6个月通畅丢失风险。

局限性

  • 原文摘要未报告具体局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Peripheral arterial disease (PAD) is highly prevalent among patients requiring hemodialysis access and reflects advanced systemic atherosclerosis. We evaluated whether PAD severity is associated with increased postoperative complications and loss of primary patency following dialysis access creation and performed stratified analyses by access type: arteriovenous fistula (AVF) and arteriovenous graft (AVG). METHODS: We used the Vascular Quality Initiative database from 2011 to 2024, including patients undergoing upper-extremity hemodialysis access creation. PAD status was categorized as no PAD, asymptomatic PAD, claudication, or chronic limb-threatening ischemia (CLTI). Postoperative outcomes included 30-day mortality, prolonged length of stay, bleeding, thrombosis, and steal syndrome. Six-month primary patency was defined as time to first intervention, thrombosis, failure, or abandonment. Multivariable logistic and Cox regression analyses were performed in the overall cohort, followed by subgroup analyses stratified by AVF and AVG. RESULTS: A total of 78,607 patients were included (25,718 [32.7%] no PAD; 47,771 [60.8%] asymptomatic PAD; 2079 [2.6%] claudication; and 3039 [3.9%] CLTI). In the overall cohort, increasing PAD severity was independently associated with worse postoperative outcomes. Compared with patients without PAD, asymptomatic PAD (adjusted odds ratio [aOR] 1.55; 95% confidence interval [CI], 1.27-1.90; P < .001), claudication (aOR 2.20; 95% CI, 1.52-3.18; P < .001), and CLTI (aOR 3.01; 95% CI, 2.24-4.06; P < .001) were associated with progressively higher odds of 30-day mortality. Asymptomatic PAD (aOR 1.41; 95% CI, 1.16-1.71; P < .001) and CLTI (aOR 2.27; 95% CI, 1.82-2.83; P < .001) were associated with prolonged length of stay. Asymptomatic PAD was also associated with increased odds of postoperative bleeding (aOR 1.30; 95% CI, 1.01-1.69; P = .043). Claudication (aOR 3.57; 95% CI, 1.33-9.59; P = .012) and CLTI (aOR 2.87; 95% CI, 1.21-6.82; P = .017) were associated with increased odds of steal syndrome, whereas PAD severity was not associated with postoperative thrombosis. At 6 months, all PAD stages were strongly associated with loss of primary patency: asymptomatic PAD (adjusted hazard ratio [aHR] 5.09; 95% CI, 3.15-8.22; P < .001), claudication (aHR 4.79; 95% CI, 2.86-8.02; P < .001), and CLTI (aHR 5.05; 95% CI, 3.14-8.10; P < .001). Findings were consistent in analyses stratified by AVF and AVG. CONCLUSIONS: To our knowledge, this is the first study to comprehensively evaluate the impact of PAD and PAD progression on outcomes and patency of dialysis access. PAD severity is independently associated with increased postoperative complications, 30-day mortality, and loss of primary patency following dialysis access creation. Notably, even asymptomatic PAD confers significantly increased risk of mortality and loss of primary patency at 6 months. These findings highlight the importance of incorporating PAD status into preoperative risk stratification and dialysis access planning.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hamouda M, Rahgozar S, Rogers UH, et al. Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery. J Vasc Surg. 2026. PMID: 42268171. doi:10.1016/j.jvs.2026.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。